© 2023 BioMarin. All rights reserved.

BioMarin to Participate in Four Upcoming Virtual Investor Conferences
- Jefferies Gene Therapy/Editing Summit on October 28 at 2:30pm ET
- Credit Suisse 30th Annual Healthcare Conference on November 10 at 1:50pm ET
- Barclays Gene Editing & Gene Therapy Summit on November 15 at 4:00pm ET
- Stifel 2021 Virtual Healthcare Conference on November 17 at 11:20am ET
Oct 25, 2021

SAN RAFAEL, Calif., Oct. 25, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in four upcoming virtual investor conferences. An audio webcast of the presentations will be available live. You can access the webcasts at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases. The Company's portfolio consists of several commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com. Information on such website is not incorporated by reference into this press release.




Traci McCarty                                                            

Debra Charlesworth

BioMarin Pharmaceutical Inc.                                      

BioMarin Pharmaceutical Inc.

(415) 455-7558                                                               

(415) 455-7451



SOURCE BioMarin Pharmaceutical Inc.